Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: J Am Coll Surg. 2012 Nov;215(5):643–651. doi: 10.1016/j.jamcollsurg.2012.07.006

Table 1.

Patient characteristics including demographics, tumor -, and treatment features

Overall Definitive RT Surgery +/− RT p-value* Preoperative RT Surgery only Postoperative RT p-value
No of pts. 2,431 1,426 (58.7) 1,005 (41.3) 369 (36.7) 476 (47.4) 160 (15.9)
Age (mean, SD), years 66.5 (11.1) 68.1 (11.1) 64.2 (10.6) <0.001 61.3 (9.4) 67.0 (10.9) 62.1 (10.3) 0.008
Female (n, %) 871 (35.8) 486 (34.1) 385 (38.3) 0.03 128 (34.7) 199 (41.8) 58 (36.3) 0.09
Race
 White 1,577 (64.9) 877 (61.5) 700 (69.7) <0.001 266 (72.1) 333 (70.0) 101 (63.1) 0.33
 Black 557 (22.9) 369 (25.9) 188 (18.7) 61 (16.5) 90 (18.9) 37 (23.1)
 Other/Unknown 297 (12.2) 180 (12.6) 117 (11.6) 42 (11.4) 53 (11.1) 22 (13.8)
Ethnicity
 Hispanic 2,283 (93.9) 1,330 (93.3) 953 (94.8) 0.11 14 (3.8) 30 (6.3) 8 (5.0) 0.26
 Non-Hispanic 148 (6.1) 96 (6.7) 52 (5.2) 355 (96.2) 446 (93.7) 152 (95.0)
Marital Status
 Married 1,279 (52.6) 693 (48.6) 586 (58.3) <0.001 251 (68.0) 245 (51.5) 90 (56.3) <0.001
 Other/Unknown 1,152 (47.4) 733 (51.4) 419 (41.7) 118 (32.0) 231 (48.5) 70 (43.8)
Tumor location
 Mid esophagus 1,469 (60.4) 948 (66.5) 521 (51.8) <0.001 208 (56.4) 227 (47.7) 86 (53.8) 0.04
 Lower esophagus 962 (39.6) 478 (33.5) 484 (48.2) 161 (43.6) 249 (52.3) 74 (46.3)
Primary tumor (T)
 T1 164 (6.7) 121 (8.5) 43 (4.3) <0.001 13 (3.5) 25 (5.3) 5 (3.1) 0.02
 T2 508 (20.9) 259 (18.2) 249 (24.8) 97 (26.3) 127 (26.7) 25 (15.6)
 T3 1,167 (48.0) 585 (41.0) 582 (57.9) 205 (55.6) 274 (57.6) 103 (64.4)
 T4 509 (20.9) 395 (27.7) 114 (11.3) 45 (12.2) 43 (9.0) 26 (16.3)
 T1/T2 83 (3.4) 66 (4.6) 17 (1.7) 9 (2.4) 7 (1.5) 1 (0.6)
Lymph node status (N)
 N0 1,046 (43.0) 594 (41.7) 452 (45.0) <0.001 161 (43.6) 235 (49.4) 56 (35.0) 0.01
 N1 1,311 (53.9) 761 (53.4) 550 (54.7) 206 (55.8) 241 (50.6) 103 (64.4)
 NX 74 (3.0) 71 (5.0) 3 (0.3) 2 (0.5) 0 (0) 1 (0.6)
Stage
 IIA 844 (34.7) 440 (30.9) 404 (40.2) <0.001 144 (39.0) 216 (45.4) 44 (27.5) <0.001
 IIB 428 (17.6) 269 (18.9) 159 (15.8) 62 (16.8) 75 (15.8) 22 (13.8)
 III 1,159 (47.7) 717 (50.3) 442 (44.0) 163 (44.2) 185 (38.9) 94 (58.8)
Tumor grade
 G1/2 (well/moderate) 1,137 (46.8) 652 (45.7) 485 (48.3) <0.001 170 (46.1) 233 (49.0) 82 (51.3) 0.05
 G3/4 (poor/undifferentiated) 944 (38.8) 493 (34.6) 451 (44.9) 163 (44.2) 221 (46.4) 67 (41.9)
 Unknown 350 (14.4) 281 (19.7) 69 (6.9) 36 (9.8) 22 (4.6) 11 (6.9)
Cause of death
 Alive 648 (26.7) 307 (21.5) 341 (33.9) <0.001 160 (43.4) 131 (27.5) 50 (31.3) <0.001
 Esophagus 1,410 (58.0) 893 (62.6) 517 (51.4) 165 (44.7) 264 (55.5) 88 (55.0)
 Other cause of death 373 (15.3) 226 (15.8) 147 (14.6) 44 (11.9) 81 (17.0) 22 (13.8)

Values are counts and % if not otherwise indicated.

*

Comparison of radiotherapy only versus others;

Comparison of surgery only, preoperative, and postoperative radiotherapy;

One-way ANOVA. RT: radiation therapy.